$APM
Aptorum Group Ltd Stock $apm

$apm Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 20-F Financial Statement

#000121390023033525 Filed on April 28, 2023

Income Statement

Concept	2022 Q4	2022	2021 Q4
Revenue	$768.4K	$1.296M	$904.0K
YoY Change	-15.0%	-15.95%	54.73%
Cost Of Revenue	$685.8K	$1.216M	$829.9K
YoY Change	-17.36%	-16.72%	43.38%
Gross Profit	$82.60K	$80.07K	$74.05K
YoY Change	11.55%	-2.19%	1273.84%
Gross Profit Margin	10.75%	6.18%	8.19%
Selling, General & Admin	$4.295M	$7.965M	$4.110M
YoY Change	4.5%	2.17%	0.46%
% of Gross Profit	5199.5%	9947.61%	5549.87%
Research & Development	$4.143M	$9.220M	$4.878M
YoY Change	-15.08%	-6.95%	-31.02%
% of Gross Profit	5015.34%	11514.42%	6587.98%
Depreciation & Amortization	$624.8K	$1.208M	$595.7K
YoY Change	4.88%	1.25%	-5.74%
% of Gross Profit	756.42%	1508.07%	804.48%
Operating Expenses	$9.140M	$18.81M	$9.787M
YoY Change	-6.61%	-2.51%	-14.14%
Operating Profit	-$9.058M	-$18.72M	-$9.713M
YoY Change	-6.75%	-2.51%	-14.75%
Interest Expense	-$54.60K	$146.6K	-$358.8K
YoY Change	-84.78%	-101.82%	-101.55%
% of Operating Profit
Other Income/Expense, Net	$316.9K	$5.984M	$63.70K
YoY Change	397.46%	3988.84%	-77.68%
Pretax Income	-$8.795M	-$11.53M	-$10.01M
YoY Change	-12.15%	-57.49%	-184.07%
Income Tax
% Of Pretax Income
Net Earnings	-$7.914M	-$11.53M	-$8.967M
YoY Change	-11.74%	-53.99%	-167.57%
Net Earnings / Revenue	-1029.93%	-889.36%	-991.93%
Basic Earnings Per Share		-$2.75
Diluted Earnings Per Share	-$2.22	-$2.75	-$250.6K
COMMON SHARES
Basic Shares Outstanding		3.569M shares
Diluted Shares Outstanding		3.569M shares

Balance Sheet

Concept	2022 Q4	2022	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.985M	$1.985M	$8.368M
YoY Change	-76.28%	-76.28%	-73.75%
Cash & Equivalents	$5.013M		$8.261M
Short-Term Investments	$102.5K	$102.5K	$236.6K
Other Short-Term Assets	$3.648M	$3.648M	$652.5K
YoY Change	459.04%	459.04%	-53.22%
Inventory	$27.72K	$27.72K	$35.78K
Prepaid Expenses
Receivables	$174.4K	$174.4K	$78.72K
Other Receivables	$1.233M	$1.233M	$3.553M
Total Short-Term Assets	$7.068M	$7.068M	$12.69M
YoY Change	-44.3%	-44.3%	-62.3%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.825M	$3.172M	$3.886M
YoY Change	-27.29%	-18.36%	-25.76%
Goodwill
YoY Change
Intangibles	$752.7K		$880.3K
YoY Change	-14.49%
Long-Term Investments	$0.00	$9.745M	$4.157M
YoY Change	-100.0%	134.43%	1.89%
Other Assets	$129.9K	$129.9K	$296.2K
YoY Change	-56.17%	-56.17%	0.0%
Total Long-Term Assets	$13.80M	$13.80M	$9.219M
YoY Change	49.69%	49.69%	-12.82%
TOTAL ASSETS
Total Short-Term Assets	$7.068M	$7.068M	$12.69M
Total Long-Term Assets	$13.80M	$13.80M	$9.219M
Total Assets	$20.87M	$20.87M	$21.91M
YoY Change	-4.75%	-4.75%	-50.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$790.3K	$790.3K	$685.2K
YoY Change	15.34%	15.34%	-26.86%
Accrued Expenses	$5.396M	$5.396M	$3.319M
YoY Change	62.56%	62.56%	32.15%
Deferred Revenue
YoY Change
Short-Term Debt	$6.026M	$6.026M	$11.39K
YoY Change	52805.44%	52805.44%	-92.19%
Long-Term Debt Due	$0.00	$0.00	$47.92K
YoY Change	-100.0%	-100.0%	-3.0%
Total Short-Term Liabilities	$12.50M	$12.50M	$4.377M
YoY Change	185.64%	185.64%	13.15%
LONG-TERM LIABILITIES
Long-Term Debt	$129.8K	$500.0K	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$30.78K	$30.78K	$23.85K
YoY Change	29.06%	29.06%	-84.62%
Total Long-Term Liabilities	$129.8K	$530.8K	$23.85K
YoY Change	444.43%	2125.49%	-98.92%
TOTAL LIABILITIES
Total Short-Term Liabilities	$12.50M	$12.50M	$4.377M
Total Long-Term Liabilities	$129.8K	$530.8K	$23.85K
Total Liabilities	$13.03M	$5.155M	-$1.700M
YoY Change	-866.66%	-403.23%	-170.92%
SHAREHOLDERS EQUITY
Retained Earnings	-$65.34M		-$55.54M
YoY Change	17.64%
Common Stock	$13.27M		$13.20M
YoY Change	0.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.71M	$15.71M	$23.61M
YoY Change
Total Liabilities & Shareholders Equity	$20.87M	$20.87M	$21.91M
YoY Change	-4.75%	-4.75%	-50.47%

Cashflow Statement

Concept	2022 Q4	2022	2021 Q4
OPERATING ACTIVITIES
Net Income	-$7.914M	-$11.53M	-$8.967M
YoY Change	-11.74%	-53.99%	-167.57%
Depreciation, Depletion And Amortization	$624.8K	$1.208M	$595.7K
YoY Change	4.88%	1.25%	-5.74%
Cash From Operating Activities	-$5.406M	-$12.32M	-$7.898M
YoY Change	-31.55%	-15.92%	-11.32%
INVESTING ACTIVITIES
Capital Expenditures	$36.37K	$186.9K	-$126.5K
YoY Change	-128.76%	-235.66%	17.38%
Acquisitions
YoY Change
Other Investing Activities	-$230.2K	$2.632M	-$3.358M
YoY Change	-93.14%	-84.19%	-419.43%
Cash From Investing Activities	-$266.6K	$2.445M	-$3.485M
YoY Change	-92.35%	-85.19%	-469.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00	$694.2K
YoY Change		-100.0%	-91.6%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	3.489M	$6.625M	-422.4K
YoY Change	-926.09%	138.26%	-105.66%
NET CHANGE
Cash From Operating Activities	-5.406M	-$12.32M	-7.898M
Cash From Investing Activities	-266.6K	$2.445M	-3.485M
Cash From Financing Activities	3.489M	$6.625M	-422.4K
Net Change In Cash	-2.183M	-$3.249M	-11.80M
YoY Change	-81.51%	-170.07%	2269.72%
FREE CASH FLOW
Cash From Operating Activities	-$5.406M	-$12.32M	-$7.898M
Capital Expenditures	$36.37K	$186.9K	-$126.5K
Free Cash Flow	-$5.442M	-$12.51M	-$7.771M
YoY Change	-29.97%	-13.83%	-11.67%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2020	apm	Gain On Derecognition Of Nonfinancial Assets GainOnDerecognitionOfNonfinancialAssets		usd
CY2022	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating		usd
CY2020	apm	Loss On Disposal Of Subsidiaries LossOnDisposalOfSubsidiaries		usd
CY2022	apm	Deemed Dividend Related To Warrants Down Round Provision DeemedDividendRelatedToWarrantsDownRoundProvision		usd
CY2022	apm	Comprehensive Incomeloss Deemed Dividend Related To Warrants Down Round Provision ComprehensiveIncomelossDeemedDividendRelatedToWarrantsDownRoundProvision		usd
CY2020	apm	Issuance Of Shares To Noncontrolling Interest IssuanceOfSharesToNoncontrollingInterest		usd
CY2020	apm	Warrant Exchange WarrantExchange		usd
CY2020	apm	Exercise Of Warrants ExerciseOfWarrants		usd
CY2022	apm	Issuance Of Shares To Noncontrolling Interest IssuanceOfSharesToNoncontrollingInterest		usd
CY2021	apm	Gain On Nonmarketable Investments GainOnNonmarketableInvestments		usd
CY2020	apm	Gain On Nonmarketable Investments GainOnNonmarketableInvestments		usd
CY2022	apm	Gain Loss On Investments In Derivatives Net GainLossOnInvestmentsInDerivativesNet		usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2020	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2021	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets		usd
CY2020	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets		usd
CY2022	apm	Loss On Disposal Of Subsidiaries LossOnDisposalOfSubsidiaries		usd
CY2020	apm	Loss On Disposal Of Subsidiaries LossOnDisposalOfSubsidiaries		usd
CY2022	apm	Gain On Use Of Digitals Currencies GainOnUseOfDigitalsCurrencies		usd
CY2020	apm	Gain On Use Of Digitals Currencies GainOnUseOfDigitalsCurrencies		usd
CY2022	apm	Settlement Of Service Fee By Digital Currencies And Tokens SettlementOfServiceFeeByDigitalCurrenciesAndTokens		usd
CY2022	dei	Document Type DocumentType	20-F
CY2022	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-38764
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	17 Hanover Square
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	London
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	W1S 1BN
CY2022	dei	Entity Address Country EntityAddressCountry	GB
CY2022	dei	Security12b Title Security12bTitle	Class A Ordinary shares, par value $0.00001
CY2022	dei	Trading Symbol TradingSymbol	APM
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022	dei	Auditor Firm AuditorFirmId	5395
CY2022	dei	Auditor Name AuditorName	Marcum Asia CPAs LLP
CY2022	dei	Auditor Location AuditorLocation	New York, NY
CY2022Q4	us-gaap	Cash Cash	1882545	usd
CY2021Q4	us-gaap	Cash Cash	8131217	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	3130335	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	130270	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	174426	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	78722	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	27722	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	35775	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	102481	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	236615	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	129677	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	47754	usd
CY2022Q4	apm	Due From Brokers DueFromBrokers	652	usd
CY2021Q4	apm	Due From Brokers DueFromBrokers	76380	usd
CY2022Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	875956	usd
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	3358089	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	744008	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	593478	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	7067802	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	12688300	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2825059	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3731116	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	347000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	154439	usd
CY2022Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	9744958	usd
CY2021Q4	us-gaap	Assets Held In Trust AssetsHeldInTrust	4156907	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	752705	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	880256	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	129847	usd
CY2021Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	296225	usd
CY2022Q4	us-gaap	Assets Assets	20867371	usd
CY2021Q4	us-gaap	Assets Assets	21907243	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	12693	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	11389	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6166807	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4172565	usd
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	47923	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	310548	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	145391	usd
CY2022Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	3000000	usd
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3013234	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12503282	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4377268	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30784	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	23853	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	500000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	13034066	usd
CY2021Q4	us-gaap	Liabilities Liabilities	4401121	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	13269528	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	13202408	usd
CY2022Q4	apm	Common Stock Value1 CommonStockValue1	22437754	usd
CY2021Q4	apm	Common Stock Value1 CommonStockValue1	22437754	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	45308080	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	43506717	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	33807	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2019	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-65337075	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-55537515	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15712094	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23607345	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-7878789	usd
CY2021Q4	us-gaap	Minority Interest MinorityInterest	-6101223	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7833305	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17506122	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20867371	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21907243	usd
CY2022	apm	Healthcare Service Income HealthcareServiceIncome	1295889	usd
CY2021	apm	Healthcare Service Income HealthcareServiceIncome	1541778	usd
CY2020	apm	Healthcare Service Income HealthcareServiceIncome	911509	usd
CY2022	apm	Cost Of Healthcare Service CostOfHealthcareService	1215824	usd
CY2021	apm	Cost Of Healthcare Service CostOfHealthcareService	1459924	usd
CY2020	apm	Cost Of Healthcare Service CostOfHealthcareService	1015023	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9219595	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10869642	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11586923	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5220405	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5409302	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4853488	usd
CY2022	apm	Legal And Professional Fees LegalAndProfessionalFees	2888140	usd
CY2021	apm	Legal And Professional Fees LegalAndProfessionalFees	2617834	usd
CY2020	apm	Legal And Professional Fees LegalAndProfessionalFees	2854225	usd
CY2022	us-gaap	Other Expenses OtherExpenses	261038	usd
CY2021	us-gaap	Other Expenses OtherExpenses	392511	usd
CY2020	us-gaap	Other Expenses OtherExpenses	877391	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	18805002	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	20749213	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	21187050	usd
CY2022	apm	Loss Gain On Investments In Marketable Securities Net LossGainOnInvestmentsInMarketableSecuritiesNet	-134134	usd
CY2021	apm	Loss Gain On Investments In Marketable Securities Net LossGainOnInvestmentsInMarketableSecuritiesNet	-8031595	usd
CY2020	apm	Loss Gain On Investments In Marketable Securities Net LossGainOnInvestmentsInMarketableSecuritiesNet	25241556	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	5588051	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2021	apm	Gain Loss On Investments In Derivatives Net GainLossOnInvestmentsInDerivativesNet	-4289	usd
CY2020	apm	Gain Loss On Investments In Derivatives Net GainLossOnInvestmentsInDerivativesNet	-199031	usd
CY2021	apm	Gain On Use Of Digital Currencies GainOnUseOfDigitalCurrencies	-4918	usd
CY2021	apm	Gain On Derecognition Of Nonfinancial Assets GainOnDerecognitionOfNonfinancialAssets	75000	usd
CY2022	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	146588	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-93601	usd
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-243628	usd
CY2020	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	30894	usd
CY2021	apm	Loss On Disposal Of Subsidiaries LossOnDisposalOfSubsidiaries	3638	usd
CY2022	apm	Sundry Income SundryIncome	383506	usd
CY2021	apm	Sundry Income SundryIncome	146347	usd
CY2020	apm	Sundry Income SundryIncome	365917	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	5984011	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7906858	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	25195708	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-11525102	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-27114293	usd
CY2020	us-gaap	Profit Loss ProfitLoss	4920167	usd
CY2022	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-1725542	usd
CY2021	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-2065904	usd
CY2020	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-2146687	usd
CY2020	apm	Deemed Dividend Related To Warrants Down Round Provision DeemedDividendRelatedToWarrantsDownRoundProvision	755514	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9799560	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25048389	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6311340	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11525102	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-27114293	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4920167	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	35826	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-55315	usd
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	58848	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	35826	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-55315	usd
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	58848	usd
CY2022	apm	Impairment Loss Of Property Plant And Equipment ImpairmentLossOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-11489276	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27169608	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	4979015	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1725542	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2065904	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-2146687	usd
CY2020	apm	Comprehensive Incomeloss Deemed Dividend Related To Warrants Down Round Provision ComprehensiveIncomelossDeemedDividendRelatedToWarrantsDownRoundProvision	755514	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9763734	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-25103704	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6370188	usd
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	14851752	usd
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	16782335	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1478565	usd
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	60626	usd
CY2020	apm	Exchange Difference On Translation Of Foreign Operation ExchangeDifferenceOnTranslationOfForeignOperation	58848	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4920167	usd
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	38152293	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	4000000	usd
CY2021	apm	Issuance Of Shares To Noncontrolling Interest IssuanceOfSharesToNoncontrollingInterest	5360	usd
CY2021	apm	Disposal Of Subsidiaries Under Common Control Transaction DisposalOfSubsidiariesUnderCommonControlTransaction	-1967	usd
CY2021	apm	Disposal Of Subsidiaries DisposalOfSubsidiaries	7962	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1682460	usd
CY2021	apm	Exercise Of Warrants ExerciseOfWarrants	130012	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	694224	usd
CY2021	apm	Exchange Difference On Translation Of Foreign Operation ExchangeDifferenceOnTranslationOfForeignOperation	-49929	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-27114293	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	17506122	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1646999	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	169460	usd
CY2022	apm	Exchange Difference On Translation Of Foreign Operation ExchangeDifferenceOnTranslationOfForeignOperation	35826	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11525102	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7833305	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-11525102	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-27114293	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	4920167	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1207510	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1192578	usd
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1334661	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1646999	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1682460	usd
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	1478565	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	-134134	usd
CY2021	us-gaap	Gain Loss On Investments GainLossOnInvestments	-8031595	usd
CY2020	us-gaap	Gain Loss On Investments GainLossOnInvestments	25241556	usd
CY2022	apm	Gain On Nonmarketable Investments GainOnNonmarketableInvestments	5588051	usd
CY2021	apm	Gain Loss On Investments In Derivatives Net GainLossOnInvestmentsInDerivativesNet	-4289	usd
CY2020	apm	Gain Loss On Investments In Derivatives Net GainLossOnInvestmentsInDerivativesNet	-199031	usd
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	75000	usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-205189	usd
CY2021	apm	Loss On Disposal Of Subsidiaries LossOnDisposalOfSubsidiaries	3638	usd
CY2021	apm	Gain On Use Of Digitals Currencies GainOnUseOfDigitalsCurrencies	4918	usd
CY2021	apm	Settlement Of Service Fee By Digital Currencies And Tokens SettlementOfServiceFeeByDigitalCurrenciesAndTokens	-90457	usd
CY2020	apm	Settlement Of Service Fee By Digital Currencies And Tokens SettlementOfServiceFeeByDigitalCurrenciesAndTokens	-24000	usd
CY2022	apm	Operating Lease Costs OperatingLeaseCosts	349031	usd
CY2021	apm	Operating Lease Costs OperatingLeaseCosts	425280	usd
CY2020	apm	Operating Lease Costs OperatingLeaseCosts	483398	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-392	usd
CY2020	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-50197	usd
CY2020	apm	Impairment Loss Of Property Plant And Equipment ImpairmentLossOfPropertyPlantAndEquipment	330445	usd
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	200000	usd
CY2022	apm	Interest Income InterestIncome	235560	usd
CY2021	apm	Interest Income InterestIncome	41246	usd
CY2020	apm	Interest Income InterestIncome	825	usd
CY2022	apm	Interest Expense And Accretion Of Convertible Debts InterestExpenseAndAccretionOfConvertibleDebts	87537	usd
CY2021	apm	Interest Expense And Accretion Of Convertible Debts InterestExpenseAndAccretionOfConvertibleDebts	130397	usd
CY2020	apm	Interest Expense And Accretion Of Convertible Debts InterestExpenseAndAccretionOfConvertibleDebts	237163	usd
CY2022	apm	Accretion Of Finance Lease Obligation AccretionOfFinanceLeaseObligation	1435	usd
CY2021	apm	Accretion Of Finance Lease Obligation AccretionOfFinanceLeaseObligation	4450	usd
CY2020	apm	Accretion Of Finance Lease Obligation AccretionOfFinanceLeaseObligation	7290	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	95704	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	16501	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	21678	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-8053	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3358	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4948	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	105584	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-695308	usd
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	358365	usd
CY2022	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-19328	usd
CY2020	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	-20	usd
CY2022	us-gaap	Increase Decrease Due From Other Related Parties IncreaseDecreaseDueFromOtherRelatedParties	-75728	usd
CY2021	us-gaap	Increase Decrease Due From Other Related Parties IncreaseDecreaseDueFromOtherRelatedParties	-83957	usd
CY2020	us-gaap	Increase Decrease Due From Other Related Parties IncreaseDecreaseDueFromOtherRelatedParties	-156668	usd
CY2022	apm	Increase Decrease In Due From Related Party IncreaseDecreaseInDueFromRelatedParty	46349	usd
CY2021	apm	Increase Decrease In Due From Related Party IncreaseDecreaseInDueFromRelatedParty	-112635	usd
CY2020	apm	Increase Decrease In Due From Related Party IncreaseDecreaseInDueFromRelatedParty	-50962	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-6805	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-264934	usd
CY2020	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-120560	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	1918751	usd
CY2021	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	855272	usd
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	800960	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-369505	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-450807	usd
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-457508	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12318965	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-14651633	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15931913	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	6026	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	186916	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	131750	usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	161314	usd
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	1051282	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	113830	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	20116734	usd
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	952196	usd
CY2022	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	330341	usd
CY2021	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	3358089	usd
CY2022	apm	Repayment Of A Loan From A Third Party RepaymentOfALoanFromAThirdParty	2962153	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2444896	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	16507039	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1842164	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	500000	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	3500000	usd
CY2020	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1000000	usd
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5489665	usd
CY2020	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	5306558	usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	5360	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4000000	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	17497426	usd
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	715091	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	169460	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	694224	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	130012	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	3000000	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	3000000	usd
CY2022	apm	Payment Of Finance Lease Obligations PaymentOfFinanceLeaseObligations	49358	usd
CY2021	apm	Payment Of Finance Lease Obligations PaymentOfFinanceLeaseObligations	53846	usd
CY2020	apm	Payment Of Finance Lease Obligations PaymentOfFinanceLeaseObligations	53845	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6625462	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2780725	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12421932	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3248607	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4636131	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1667817	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8261487	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3625356	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5293173	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5012880	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8261487	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3625356	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	64744	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	273155	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	131554	usd
CY2021	apm	Proceeds In Broker Accounts ProceedsInBrokerAccounts	20116734	usd
CY2020	apm	Proceeds In Broker Accounts ProceedsInBrokerAccounts	952196	usd
CY2022	apm	Right Of Use Assets Obtained In Exchange For Operating Lease Liability RightOfUseAssetsObtainedInExchangeForOperatingLeaseLiability	549596	usd
CY2020	apm	Right Of Use Assets Obtained In Exchange For Operating Lease Liability RightOfUseAssetsObtainedInExchangeForOperatingLeaseLiability	1107206	usd
CY2021	apm	Settlements Of Service Fee By Digital Currencies And Tokens SettlementsOfServiceFeeByDigitalCurrenciesAndTokens	90457	usd
CY2020	apm	Settlements Of Service Fee By Digital Currencies And Tokens SettlementsOfServiceFeeByDigitalCurrenciesAndTokens	24000	usd
CY2020	apm	Deemed Dividend Related To Warrants Down Round Provisions DeemedDividendRelatedToWarrantsDownRoundProvisions	755514	usd
CY2022	apm	Reconcilation Cash ReconcilationCash	1882545	usd
CY2021	apm	Reconcilation Cash ReconcilationCash	8131217	usd
CY2020	apm	Reconcilation Cash ReconcilationCash	3495231	usd
CY2022	apm	Reconcilation Of Restricted Cash ReconcilationOfRestrictedCash	3130335	usd
CY2021	apm	Reconcilation Of Restricted Cash ReconcilationOfRestrictedCash	130270	usd
CY2020	apm	Reconcilation Of Restricted Cash ReconcilationOfRestrictedCash	130125	usd
CY2022	apm	Reconciliationof Cashand Restricted Cash ReconciliationofCashandRestrictedCash	5012880	usd
CY2021	apm	Reconciliationof Cashand Restricted Cash ReconciliationofCashandRestrictedCash	8261487	usd
CY2020	apm	Reconciliationof Cashand Restricted Cash ReconciliationofCashandRestrictedCash	3625356	usd
CY2022	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	-11525102	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-12318965	usd
CY2022Q4	apm	Retained Earning Accumulated Deficit RetainedEarningAccumulatedDeficit	65337075	usd
CY2022Q4	apm	Unrestricted Cash Equivalents UnrestrictedCashEquivalents	3000000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="text-decoration:underline">Use of estimates</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements as well as income and expenses during the reporting period. Significant accounting estimates reflected in the Group’s consolidated financial statements include valuation of equity securities, fair value of investments in securities, convertible debts, finance lease, warrants and share options, the useful lives of intangible assets and property, plant and equipment, impairment of long-lived assets, valuation allowance for deferred tax assets, and collectability of receivables. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	23508	usd
CY2022Q4	us-gaap	Bad Debt Reserve For Tax Purposes Of Qualified Lender BadDebtReserveForTaxPurposesOfQualifiedLender	71	usd
CY2022Q4	apm	Other Receivables And Prepayments Current OtherReceivablesAndPrepaymentsCurrent	744008	usd
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.50	pure
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	179681	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	77200	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	47697	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	21603	usd
CY2022	apm	Upward Adjustments UpwardAdjustments	6108872	usd
CY2022	apm	Downward Adjustments And Impairment DownwardAdjustmentsAndImpairment	-520821	usd
CY2022	apm	Total Unrealized Gain For Nonmarketable Investments TotalUnrealizedGainForNonmarketableInvestments	5588051	usd
CY2022Q4	apm	Initial Cost Basis InitialCostBasis	4079707	usd
CY2021Q4	apm	Initial Cost Basis InitialCostBasis	4079707	usd
CY2022Q4	apm	Upward Adjustment UpwardAdjustment	6108872	usd
CY2022Q4	apm	Downward Adjustment And Impairment DownwardAdjustmentAndImpairment	-520821	usd
CY2022Q4	apm	Total Carrying Value At The End Of The Period TotalCarryingValueAtTheEndOfThePeriod	9667758	usd
CY2021Q4	apm	Total Carrying Value At The End Of The Period TotalCarryingValueAtTheEndOfThePeriod	4079707	usd
CY2022	us-gaap	Key Provisions Of Operating Or Partnership Agreement Description KeyProvisionsOfOperatingOrPartnershipAgreementDescription	Each Class A share of Libra is entitled to 1 vote while each Class B share of Libra is entitled to 10 votes.
CY2022Q4	apm	Noncontrolling Interest Ownership Percentage By Noncontrolling Owners NoncontrollingInterestOwnershipPercentageByNoncontrollingOwners	0.9727	pure
CY2022Q4	apm	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	305178	usd
CY2021Q4	apm	Prepaid Research And Development Expenses PrepaidResearchAndDevelopmentExpenses	314165	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	47833	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	92035	usd
CY2022Q4	apm	Prepaid Service Fee PrepaidServiceFee	148346	usd
CY2021Q4	apm	Prepaid Service Fee PrepaidServiceFee	90857	usd
CY2022Q4	apm	Rental Deposits RentalDeposits	16296	usd
CY2021Q4	apm	Rental Deposits RentalDeposits	12011	usd
CY2021Q4	us-gaap	Prepaid Rent PrepaidRent	13205	usd
CY2022Q4	us-gaap	Other Receivables OtherReceivables	204752	usd
CY2021Q4	apm	Other Receivables And Prepayments Current OtherReceivablesAndPrepaymentsCurrent	593478	usd
CY2020Q4	apm	Digital Currencies DigitalCurrencies	1539	usd
CY2021Q4	apm	Utilization Of Digital Currencies To Settle Service Fee UtilizationOfDigitalCurrenciesToSettleServiceFee	6457	usd
CY2021	apm	Gain On Use Of Digital Currency GainOnUseOfDigitalCurrency	4918	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7395514	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	7209458	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4570455	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3478342	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2825059	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3731116	usd
CY2022	us-gaap	Depreciation Depreciation	1092957	usd
CY2021	us-gaap	Depreciation Depreciation	1086564	usd
CY2020	us-gaap	Depreciation Depreciation	1128867	usd
CY2020	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	330445	usd
CY2021	apm	Loss On Disposal Of Office Equipment LossOnDisposalOfOfficeEquipment	392	usd
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	50197	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1262063	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1369872	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	509358	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	489616	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	752705	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	880256	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	114553	usd
CY2021	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	106014	usd
CY2020	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	145961	usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-205189	usd
CY2020	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	200000	usd
CY2021	apm	Wrote Off Of Cost Related Amortization WroteOffOfCostRelatedAmortization	1344	usd
CY2020	apm	Wrote Off Of Cost Related Amortization WroteOffOfCostRelatedAmortization	70477	usd
CY2022	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P5Y
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	146584	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	138956	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	119713	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	119713	usd
CY2022Q4	apm	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	106795	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	326133	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	957894	usd
CY2022Q4	us-gaap	Customer Deposits Noncurrent CustomerDepositsNoncurrent	127303	usd
CY2021Q4	us-gaap	Customer Deposits Noncurrent CustomerDepositsNoncurrent	149175	usd
CY2022Q4	apm	Prepayments For Equipment PrepaymentsForEquipment	2544	usd
CY2021Q4	apm	Prepayments For Equipment PrepaymentsForEquipment	147050	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	129847	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	296225	usd
CY2022Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	5084969	usd
CY2021Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	3173739	usd
CY2022Q4	apm	Payables For Leasehold Improvement And Equipment PayablesForLeaseholdImprovementAndEquipment	563913	usd
CY2021Q4	apm	Payables For Leasehold Improvement And Equipment PayablesForLeaseholdImprovementAndEquipment	519012	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	226407	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	166190	usd
CY2022Q4	apm	Cost Of Healthcare Services Payable CostOfHealthcareServicesPayable	138316	usd
CY2021Q4	apm	Cost Of Healthcare Services Payable CostOfHealthcareServicesPayable	142968	usd
CY2022Q4	apm	Insurance Expense Payable InsuranceExpensePayable	33367	usd
CY2021Q4	apm	Insurance Expense Payable InsuranceExpensePayable	35010	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	119835	usd
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	135646	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	6166807	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	4172565	usd
CY2022	apm	Schedule Of Income Taxes Expenses Statutory Tax Rate ScheduleOfIncomeTaxesExpensesStatutoryTaxRate	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended<br/> December 31, <br/> 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended<br/> December 31, <br/> 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year ended<br/> December 31, <br/> 2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%; text-align: left">Net income (loss) before tax</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(11,525,102</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(27,114,293</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">4,920,167</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Provision for income taxes at Hong Kong statutory income tax rate (16.5%)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(1,901,642</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,473,859</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">811,828</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Impact of different tax rates in other jurisdictions</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(263,787</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(214,135</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(18,869</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Non-taxable income</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(907,495</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(716,628</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,281,521</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Non-deductible expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-215">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,992,463</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,200</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt">Change in valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,072,924</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,412,159</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,409,362</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 4pt">Effective income tax expense</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-216">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-217">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-218">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> </p>
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-11525102	usd
CY2021	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-27114293	usd
CY2020	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	4920167	usd
CY2022	apm	Provision For Income Taxes At Hong Kong Statutory Income Tax Rate ProvisionForIncomeTaxesAtHongKongStatutoryIncomeTaxRate	-0.165	pure
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-1901642	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	-4473859	usd
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	811828	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-263787	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-214135	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-18869	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-907495	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-716628	usd
CY2020	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	-4281521	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1992463	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	79200	usd
CY2022	apm	Income Tax Reconciliation Change In Valuation Allowance IncomeTaxReconciliationChangeInValuationAllowance	3072924	usd
CY2021	apm	Income Tax Reconciliation Change In Valuation Allowance IncomeTaxReconciliationChangeInValuationAllowance	3412159	usd
CY2020	apm	Income Tax Reconciliation Change In Valuation Allowance IncomeTaxReconciliationChangeInValuationAllowance	3409362	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	14865121	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	12189424	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	948893	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	698564	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	15814014	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12887988	usd
CY2022Q4	apm	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	108926	usd
CY2021Q4	apm	Deferred Tax Liabilities Depreciation And Amortization DeferredTaxLiabilitiesDepreciationAndAmortization	255824	usd
CY2022Q4	apm	Valuation Allowance ValuationAllowance	15705088	usd
CY2021Q4	apm	Valuation Allowance ValuationAllowance	12632164	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15705088	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12632164	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	90060983	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	73785041	usd
CY2021Q4	apm	Loss Carryforward Cancelled LossCarryforwardCancelled	1805527	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12632164	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9561560	usd
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6152198	usd
CY2022	apm	Valuation Allowance Deferred Tax Asset Increase ValuationAllowanceDeferredTaxAssetIncrease	3072924	usd
CY2021	apm	Valuation Allowance Deferred Tax Asset Increase ValuationAllowanceDeferredTaxAssetIncrease	3412159	usd
CY2020	apm	Valuation Allowance Deferred Tax Asset Increase ValuationAllowanceDeferredTaxAssetIncrease	3409362	usd
CY2021	apm	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount	-341555	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15705088	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	12632164	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	9561560	usd
CY2022Q4	us-gaap	Due From Other Related Parties DueFromOtherRelatedParties	1005633	usd
CY2021Q4	us-gaap	Due From Other Related Parties DueFromOtherRelatedParties	3405843	usd
CY2022Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	3025927	usd
CY2021Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	11389	usd
CY2022Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	500000	usd
CY2019Q3	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	15000000	usd
CY2019Q3	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	9500000	usd
CY2021Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	700000	aud
CY2021Q4	apm	Loans Interestbearing Rate LoansInterestbearingRate	0.10	pure
CY2022Q1	us-gaap	Line Of Credit LineOfCredit	1000000	usd
CY2022Q1	us-gaap	Long Term Debt Maturity Date LongTermDebtMaturityDate	2023-01-12
CY2022Q1	us-gaap	Line Of Credit Facility Expiration Period LineOfCreditFacilityExpirationPeriod	P3Y
CY2022Q1	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.10	pure
CY2022Q1	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	400000	usd
CY2022Q4	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.3456	pure
CY2022Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3000000	usd
CY2022Q4	us-gaap	Maturity Of Time Deposits MaturityOfTimeDeposits	P12M
CY2022Q4	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.07	pure
	us-gaap	Landing Fees And Other Rentals LandingFeesAndOtherRentals	130000	hkd
	us-gaap	Landing Fees And Other Rentals LandingFeesAndOtherRentals	16667	usd
CY2023Q1	us-gaap	Shares Issued SharesIssued	122	shares
CY2022Q1	apm	Services Fees ServicesFees	25000	hkd
CY2022Q1	apm	Services Fees ServicesFees	3205	usd
CY2021Q2	apm	Consideration Amount ConsiderationAmount	1	usd
CY2021Q2	us-gaap	Related Party Tax Expense Effect Of Change In Allocation Methodology RelatedPartyTaxExpenseEffectOfChangeInAllocationMethodology	303419	usd
CY2021Q4	us-gaap	Common Stock Voting Rights CommonStockVotingRights	each Class A ordinary share is entitled to 1 vote and 1 share of economic benefit of the respective company, while each Class B ordinary share is entitled to 10 votes
CY2022Q4	apm	Share Of Economic ShareOfEconomic	0.001
CY2021Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P0Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2021	apm	Impairment Loss Of Property Plant And Equipment ImpairmentLossOfPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Other Assets OtherAssets	61630	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	86306	usd
CY2022Q4	us-gaap	Assets Net AssetsNet	-22676	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	5361	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	2266	usd
CY2021Q4	us-gaap	Assets Net AssetsNet	3095	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	0	usd
CY2022Q1	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	25000	hkd
CY2022Q1	us-gaap	Longterm Debt Percentage Bearing Fixed Interest Amount LongtermDebtPercentageBearingFixedInterestAmount	3205	usd
CY2022Q1	us-gaap	Line Of Credit Facility Description LineOfCreditFacilityDescription	On January 13, 2022, the Group entered a line of credit facility with Libra Sciences Limited to provide up to a total $1 million line of credit for its daily operation. The line of credit is originally matured on January 12, 2023, and is extended for additional 3 years.
CY2022Q1	apm	Principal Indebtedness PrincipalIndebtedness	0.10	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y1M6D
CY2022Q4	apm	Operating Lease Weighted Average Discount Rate OperatingLeaseWeightedAverageDiscountRate	0.08	pure
CY2022	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	47818	usd
CY2021	us-gaap	Cost Of Goods And Services Sold Depreciation CostOfGoodsAndServicesSoldDepreciation	47819	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	1435	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4450	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	349031	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	425280	usd
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	85598	usd
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	86125	usd
CY2022	us-gaap	Lease Cost LeaseCost	483882	usd
CY2021	us-gaap	Lease Cost LeaseCost	563674	usd
CY2022	apm	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	369505	usd
CY2021	apm	Operating Cash Flows From Operating Leases OperatingCashFlowsFromOperatingLeases	450807	usd
CY2022	apm	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	49358	usd
CY2021	apm	Financing Cash Flows From Finance Leases FinancingCashFlowsFromFinanceLeases	53846	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	549596	usd
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.025	pure
CY2021Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.025	pure
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.08	pure
CY2022Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	298409	usd
CY2022Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	58434	usd
CY2022Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	356843	usd
CY2022	apm	Less Current Portion Of Finance Lease Liabilities LessCurrentPortionOfFinanceLeaseLiabilities	-15511	usd
CY2022Q4	apm	Present Value Of Finance Lease Liabilities PresentValueOfFinanceLeaseLiabilities	341332	usd
CY2022Q4	apm	Current Portion Of Operating Lease Liabilities CurrentPortionOfOperatingLeaseLiabilities	-310548	usd
CY2022Q4	apm	Noncurrent Portion Of Operating Lease Liabilitie NoncurrentPortionOfOperatingLeaseLiabilitie	30784	usd
CY2022Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	3000000	usd
CY2022Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.07	pure
CY2020Q1	apm	Gross Proceed GrossProceed	10000000	usd
CY2020Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	4324	usd
CY2020Q1	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	88.8
CY2020Q3	apm	Deemed Dividend DeemedDividend	755514	usd
CY2020Q4	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	14754	usd
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	40.625
CY2020Q4	apm	Ordinary Shares Description OrdinarySharesDescription	Following the public offering completed on October 2, 2020, the placement agent of the offering on February 28, 2020 was further received 6,541 warrants as a tail fee, with an exercise price of $39.0 and expire seven years from the date of issuance.
CY2021Q1	us-gaap	Common Stock Other Value Outstanding CommonStockOtherValueOutstanding	15000000	usd
CY2021Q2	apm	Ordinary Shares Closing Price Percentage OrdinarySharesClosingPricePercentage	0.10	pure
CY2021Q2	apm	Gross Proceed GrossProceed	4000000	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.02	pure
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	53694	shares
CY2021Q1	us-gaap	Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear	2031-12-31
CY2020Q1	us-gaap	Share Price SharePrice	29.9
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	14896	shares
CY2020Q4	us-gaap	Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear	2030-11-30
CY2020Q2	us-gaap	Share Price SharePrice	31.1
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	2748	shares
CY2020Q3	us-gaap	Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear	2031-08-09
CY2020Q3	us-gaap	Share Price SharePrice	36.4
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	75235	shares
CY2021Q1	us-gaap	Share Price SharePrice	27.6
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	36796	shares
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear	2032-12-31
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	906	shares
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear	2032-06-07
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	725	shares
CY2021Q3	us-gaap	Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear	2032-07-13
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	153146	shares
CY2022Q1	us-gaap	Share Price SharePrice	13.4
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1866	shares
CY2022Q2	us-gaap	Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear	2033-06-07
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1493	shares
CY2022Q3	us-gaap	Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear	2033-07-13
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	127404	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.91
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P11Y3D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	153146	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.4
CY2022	apm	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P12Y3M18D
CY2022	apm	Number Of Share Options Outstanding Exercised NumberOfShareOptionsOutstandingExercised	6721	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	25.25
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1268	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	28.11
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	435	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	116.71
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	272126	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	21.54
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P10Y9M29D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	89300	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	32.71
CY2022	apm	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P9Y7M20D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	71756	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	37.63
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P11Y2M19D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	75235	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	27.6
CY2021	apm	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P12Y3M14D
CY2021	apm	Number Of Share Options Outstanding Exercised NumberOfShareOptionsOutstandingExercised	19037	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	36.52
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	550	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	29
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	127404	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	31.91
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P11Y3D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	31456	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	42.62
CY2021	apm	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P9Y7M17D
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	21853	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	129.1
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P11Y6M3D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	71338	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	30.4
CY2020	apm	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm	P11Y11M26D
CY2020	apm	Number Of Share Options Outstanding Exercised NumberOfShareOptionsOutstandingExercised	1235	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	49.27
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	4594	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	46.7
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	15606	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	129.1
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	71756	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	37.63
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P11Y2M19D
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	8467	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	61.24
CY2020	apm	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm	P9Y11M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8955	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.977	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0186	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0164	pure
CY2022	us-gaap	Distribution Made To Limited Partner Unit Distribution Dilution Per Unit DistributionMadeToLimitedPartnerUnitDistributionDilutionPerUnit	1
CY2021	us-gaap	Distribution Made To Limited Partner Unit Distribution Dilution Per Unit DistributionMadeToLimitedPartnerUnitDistributionDilutionPerUnit	1
CY2022Q4	apm	Total Unrecognized Sharebased Compensation TotalUnrecognizedSharebasedCompensation	376512	usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.75
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.15
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		usd
CY2021	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2021Q4	us-gaap	Shares Issued SharesIssued	0.001	shares
CY2021Q4	apm	Adjustment Increase Decrease Retained Earnings Deficit AdjustmentIncreaseDecreaseRetainedEarningsDeficit	27293	usd
CY2022	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	2.07	usd
CY2022Q4	apm	Adjustment Increase Decrease Retained Earnings Deficit AdjustmentIncreaseDecreaseRetainedEarningsDeficit	7878789	usd
CY2021	us-gaap	Noncontrolling Interest Decrease From Deconsolidation NoncontrollingInterestDecreaseFromDeconsolidation	6101223	usd
CY2022	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable	1725542	usd
CY2021	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable	2065904	usd
CY2020	us-gaap	Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable	2146687	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9799560	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-25048389	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6311340	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3569484	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3503396	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3113588	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3569484	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3503396	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3153447	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.75
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.15
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.03
CY2022Q4	us-gaap	Purchase Obligation PurchaseObligation	50075	usd
CY2022Q4	apm	Preclinical To Ind Filing PreclinicalToIndFiling	222564	usd
CY2022Q4	apm	From Entering Phase1 To Before First Commercial Sale FromEnteringPhase1ToBeforeFirstCommercialSale	20336410	usd
CY2022Q4	apm	First Commercial Sale FirstCommercialSale	14282051	usd
CY2022Q4	apm	Net Sales Amount More Than Certain Threshold In Year NetSalesAmountMoreThanCertainThresholdInYear	65769231	usd
CY2022Q4	apm	Surgical Robotics And Medical Devices Up To Conditions And Milestones Of Subtotal SurgicalRoboticsAndMedicalDevicesUpToConditionsAndMilestonesOfSubtotal	100610256	usd
CY2022Q4	apm	Fda Approval Obtaine FdaApprovalObtaine	205554	usd
CY2022Q4	apm	Milestone Payments Total MilestonePaymentsTotal	100815810	usd
CY2020	apm	Milestone Payments MilestonePayments	129203	usd
CY2022	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	pure
CY2022	dei	Entity Registrant Name EntityRegistrantName	Aptorum Group Ltd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable		usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2020	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable		usd
CY2021	apm	Repayment Of A Loan From A Third Party RepaymentOfALoanFromAThirdParty		usd
CY2020	apm	Repayment Of A Loan From A Third Party RepaymentOfALoanFromAThirdParty		usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2020	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2020	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2020	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022	apm	Proceeds In Broker Accounts ProceedsInBrokerAccounts		usd
CY2021	apm	Right Of Use Assets Obtained In Exchange For Operating Lease Liability RightOfUseAssetsObtainedInExchangeForOperatingLeaseLiability		usd
CY2022	apm	Settlements Of Service Fee By Digital Currencies And Tokens SettlementsOfServiceFeeByDigitalCurrenciesAndTokens		usd
CY2022	apm	Deemed Dividend Related To Warrants Down Round Provisions DeemedDividendRelatedToWarrantsDownRoundProvisions		usd
CY2021	apm	Deemed Dividend Related To Warrants Down Round Provisions DeemedDividendRelatedToWarrantsDownRoundProvisions		usd
CY2021Q4	us-gaap	Bad Debt Reserve For Tax Purposes Of Qualified Lender BadDebtReserveForTaxPurposesOfQualifiedLender		usd
CY2020Q4	us-gaap	Bad Debt Reserve For Tax Purposes Of Qualified Lender BadDebtReserveForTaxPurposesOfQualifiedLender		usd
CY2021	apm	Upward Adjustments UpwardAdjustments		usd
CY2020	apm	Upward Adjustments UpwardAdjustments		usd
CY2021	apm	Downward Adjustments And Impairment DownwardAdjustmentsAndImpairment		usd
CY2020	apm	Downward Adjustments And Impairment DownwardAdjustmentsAndImpairment		usd
CY2021	apm	Total Unrealized Gain For Nonmarketable Investments TotalUnrealizedGainForNonmarketableInvestments		usd
CY2020	apm	Total Unrealized Gain For Nonmarketable Investments TotalUnrealizedGainForNonmarketableInvestments		usd
CY2021Q4	apm	Upward Adjustment UpwardAdjustment		usd
CY2021Q4	apm	Downward Adjustment And Impairment DownwardAdjustmentAndImpairment		usd
CY2022Q4	us-gaap	Prepaid Rent PrepaidRent		usd
CY2021Q4	apm	Digital Currencies DigitalCurrencies		usd
CY2022Q4	apm	Utilization Of Digital Currencies To Settle Service Fee UtilizationOfDigitalCurrenciesToSettleServiceFee		usd
CY2022	apm	Gain On Use Of Digital Currency GainOnUseOfDigitalCurrency		usd
CY2022Q4	apm	Digital Currencies DigitalCurrencies		usd
CY2021Q4	apm	Digital Currencies DigitalCurrencies		usd
CY2022	apm	Wrote Off Of Cost Related Amortization WroteOffOfCostRelatedAmortization		usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022	apm	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount		usd
CY2020	apm	Valuation Allowance Deferred Tax Asset Decrease Amount ValuationAllowanceDeferredTaxAssetDecreaseAmount		usd
CY2021Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent		usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost		usd
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost		usd
CY2022	us-gaap	Sublease Income SubleaseIncome		usd
CY2021	us-gaap	Sublease Income SubleaseIncome		usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability		usd
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate		pure
CY2021	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate		pure
CY2020	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate		pure
CY2022	apm	Milestone Payments MilestonePayments		usd
CY2021	apm	Milestone Payments MilestonePayments		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001734005

Files In Submission

Name	View Source	Status
0001213900-23-033525-index-headers.html	Edgar Link	pending
0001213900-23-033525-index.html	Edgar Link	pending
0001213900-23-033525.txt	Edgar Link	pending
0001213900-23-033525-xbrl.zip	Edgar Link	pending
apm-20221231.xsd	Edgar Link	pending
ex1-2_001.jpg	Edgar Link	pending
ex1-2_002.jpg	Edgar Link	pending
ex2-1_001.jpg	Edgar Link	pending
ex2-1_002.jpg	Edgar Link	pending
ex4-51_001.jpg	Edgar Link	pending
ex8-1_001.jpg	Edgar Link	pending
R31.htm	Edgar Link	pending
apm-20221231_pre.xml	Edgar Link	unprocessable
apm-20221231_cal.xml	Edgar Link	unprocessable
apm-20221231_def.xml	Edgar Link	unprocessable
apm-20221231_lab.xml	Edgar Link	unprocessable
f20f2022ex1-2_aptorumgroup.htm	Edgar Link	pending
f20f2022ex12-1_aptorumgroup.htm	Edgar Link	pending
f20f2022ex12-2_aptorumgroup.htm	Edgar Link	pending
f20f2022ex13-1_aptorumgroup.htm	Edgar Link	pending
f20f2022ex15-1_aptorumgroup.htm	Edgar Link	pending
f20f2022ex2-1_aptorumgroup.htm	Edgar Link	pending
f20f2022ex2-3_aptorumgroup.htm	Edgar Link	pending
f20f2022ex4-51_aptorumgroup.htm	Edgar Link	pending
f20f2022ex8-1_aptorumgroup.htm	Edgar Link	pending
f20f2022_aptorumgroup.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
f20f2022_aptorumgroup_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$APM
Aptorum Group Ltd Stock $apm

2022 Q4 Form 20-F Financial Statement

#000121390023033525 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APM Aptorum Group Ltd Stock $apm

2022 Q4 Form 20-F Financial Statement

#000121390023033525 Filed on April 28, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$APM
Aptorum Group Ltd Stock $apm